Investigators in the laboratory of Gemma Carvill, Ph.D., assistant professor in the Ken and Ruth Davee Department of Neurology Division of Epilepsy/Clinical Neurophysiology, have discovered novel ...
Researchers have deepened our understanding of two of the five members of the CDKL family of genes, CDKL2 and CDKL1. They show that variants in these genes can lead to neurodevelopmental conditions, ...
6d
Irish Mirror on MSNTeen with rare genetic disorder died due to brain bleed suffered in fall after epileptic seizure, inquest hearsThe mother of Sandra Kuzmecka wiped back tears as she heard it was clear that the girl had been lovingly cared for throughout ...
In his latest column, Gordon shares his family’s journey after his son Adam was diagnosed with epilepsy, reflecting on the ...
Feb. 19, 2025 — New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people ...
3d
Tribune Online on MSNEpilepsy affects 52 million people worldwide, more in LMIC countries, study findsEXPERTS, in recent assessment, said epilepsy, one of the most prevalent serious brain disorders marked by frequent and unprovoked seizures, affected around 52 million people of all ages in 2021, with ...
Each of us is the product of our own unique combination of identities, experiences, and interests, ultimately informing, or at a minimum influencing, our perspectives on different virtues.
Tommy Wyllie, 12, hopes first-of-its-kind study will transform the lives of young people with epilepsy.
Among simple congenital heart diseases (CHD), patent foramen ovale (PFO) is associated with a significantly higher risk for epilepsy.
The efficacy was rated according to the seizure types and epilepsy syndrome. After a mean period of 27.5 months of treatment (range 24-61 months), 11 patients (4%) were seizure free and 56 (20% ...
Valley representative Jim Costa is on a mission to bring more epilepsy care, awareness and research to the country. "One in 25 people over the course of their life will develop epilepsy," said Dr. Joe ...
Praxis' epilepsy pipeline takes center stage after Ulixacaltamide's Phase 3 futility. Key trials for vormatrigine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results